These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 4315341

  • 1. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.
    Motta R.
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):161-7. PubMed ID: 4315341
    [No Abstract] [Full Text] [Related]

  • 2. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
    Wahren B.
    J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
    [No Abstract] [Full Text] [Related]

  • 3. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A, Ito Y.
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract] [Full Text] [Related]

  • 4. Complement fixation in conventional and regressing virus-induced murine leukemia.
    Rich MA, Karl S, Clymer R.
    J Immunol; 1971 Jun; 106(6):1488-92. PubMed ID: 4326129
    [No Abstract] [Full Text] [Related]

  • 5. An indirect cytotoxicity test with increased sensitivity against the normal and leukaemic transplantation antigens.
    Motta R.
    Rev Eur Etud Clin Biol; 1970 May; 15(5):510-4. PubMed ID: 5310725
    [No Abstract] [Full Text] [Related]

  • 6. [On the effectivity in vitro of heterologous rabbit antisera against mouse leukemia cells (author's transl)].
    Milleck J.
    Arch Geschwulstforsch; 1973 May; 42(4):274-84. PubMed ID: 4138846
    [No Abstract] [Full Text] [Related]

  • 7. Comparative study of mouse leukaemias induced by Mazurenko, Friend and Graffi viruses, using the in vitro cytotoxic test.
    Zueva YN.
    Folia Biol (Praha); 1967 May; 13(5):343-9. PubMed ID: 4296203
    [No Abstract] [Full Text] [Related]

  • 8. Formation of antibodies against salmonella lipopolysaccharides during a latent infection by Friend murine leukemia virus.
    Ransom JP, Gorman JM, Tulve S.
    Cancer Res; 1969 Jul; 29(7):1407-15. PubMed ID: 5799159
    [No Abstract] [Full Text] [Related]

  • 9. The protective effect of antisera against leukaemia in vivo--a reappraisal.
    Hersey P.
    Br J Cancer Suppl; 1973 Aug; 1():11-8. PubMed ID: 4807573
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F, Genovesi EV, Collins JJ.
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [Abstract] [Full Text] [Related]

  • 11. Antigenic analysis of L strain cells: a new murine leukemia-associated antigen, "L".
    Leclerc JC, Levy JP, Varet B, Oppenheim S, Senik A.
    Cancer Res; 1970 Jul; 30(7):2073-9. PubMed ID: 4318470
    [No Abstract] [Full Text] [Related]

  • 12. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW, Cremona P, Leonard C, Stremmel P.
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract] [Full Text] [Related]

  • 13. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR, Redmon LW, Bass LR.
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Friend leukemogenic virus on antibody-forming cells to a bacterial somatic antigen.
    Hirano S, Ceglowski WS, Allen JL, Friedman H.
    J Natl Cancer Inst; 1969 Dec; 43(6):1337-45. PubMed ID: 4918854
    [No Abstract] [Full Text] [Related]

  • 15. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
    Genovesi EV, Livnat D, Collins JJ.
    J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F, Kao KJ, Pizzo SV, Collins JJ.
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G.
    Ser Haematol; 1972 Mar; 5(5):66-86. PubMed ID: 4151467
    [No Abstract] [Full Text] [Related]

  • 18. Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: II. Comparison of cells cultured with and without tumor to noncultured immune cells.
    Cheever MA, Greenberg PD, Fefer A.
    J Immunol; 1978 Dec; 121(6):2220-7. PubMed ID: 152790
    [No Abstract] [Full Text] [Related]

  • 19. A search for natural antibody against feline and murine leukemia antigen by mixed hemadsorption test.
    Maruyama K, Dmochowski L, Rickard CG.
    J Am Vet Med Assoc; 1971 Mar 15; 158(6):Suppl 2:1076+. PubMed ID: 4325038
    [No Abstract] [Full Text] [Related]

  • 20. Cell surface antigens detectable by cytotoxic test on Friend virus-induced and Friend virus-infected tumors in the rat.
    Shirai T, Kaji H, Takeichi N, Sendo F, Saito H.
    J Natl Cancer Inst; 1971 Mar 15; 46(3):449-60. PubMed ID: 5547310
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.